One public-safety audience
People who use, people who do not, families and witnesses enter through different needs but share access to emergency knowledge. No disclosure is required.
THE REAL DOPE PROJECT · PUBLIC RESEARCH NOTE 01
Safety Is for Everyone:
a testable public-safety proposition
Safety knowledge should not be rationed by identity, diagnosis, abstinence, treatment readiness or “rock bottom.” People who use substances and people who do not can learn how to recognize danger, carry naloxone, respond without shame and make help easier to reach.
Status: TRDP conceptual and knowledge-mobilization contribution · published 12 October 2026 · not peer reviewed or clinically validated · effectiveness not established
The question
What changes when substance-safety education is designed for everyone?
Most overdose education properly concentrates on people closest to risk. TRDP asks an additional public-safety question: can the circle of useful knowledge widen without displacing peer expertise, minimizing risk or turning friends and families into compulsory caregivers?
This is a design and evaluation question—not a claim that one webpage can solve structural barriers, toxic supply, poverty, criminalization, service loss or unequal healthcare.
Proposed contribution
A universal invitation with explicit safety boundaries
No rock-bottom gate
A person can learn, reduce risk, ask about treatment, take a break or change direction before crisis. Use, dependence, withdrawal, poisoning and substance use disorder remain distinct.
Voluntary roles for non-users
Someone may carry naloxone, learn the response, offer a check-in or take a turn as the substance-free driver. Helping is a choice, not an assigned identity.
Visible uncertainty
TRDP labels official guidance, project interpretation, advocacy and untested frameworks separately. Corrections and negative findings belong in the public record.
Research foundation
What the evidence supports—and where it stops
Supported foundationBoundary
Health Canada describes substance use as a spectrum and states that avoiding use is the best way to avoid substance-related harms.A spectrum is not an individual diagnosis or a prediction of harm.
Take-home naloxone is available without prescription in Canada and is intended for people at risk or likely to encounter an overdose.Availability does not guarantee local stock, access, training or willingness to carry it.
Canadian guidance and program evaluations support lay overdose education and meaningful involvement of people with lived/living expertise.Much program evidence relies on self-report; knowledge and confidence are not observed emergency performance.
Canadian survey evidence links stigmatized attitudes with public support for harm reduction.The 2018 survey is dated and observational. It does not prove TRDP wording changes attitudes.
Stigma can be measured in several ways.A 2024 review found no reviewed measure met every quality domain and found no structural-stigma measure. Evaluation must stay modest and plural.
Five propositions
Claims that can fail—and teach us something
P1 · Find the emergency action
A visitor should be able to locate “Call 911” and the overdose-response route quickly, without completing a lesson, checklist or disclosure.
Observe: Task completion, time to first correct action, wrong turns and read-aloud comprehension.
P2 · Widen belonging without minimizing risk
People who use substances and people who do not should both recognize a legitimate role for themselves.
Observe: Version-specific inclusion feedback, missing-audience reports and cognitive interviews.
P3 · Improve practical readiness
Universal education may improve knowledge of naloxone access, overdose recognition and voluntary bystander roles.
Observe: Pre/post knowledge and confidence, followed by optional evidence of kit access or training. Intention is not behaviour.
P4 · Reduce stigmatizing interpretation
Precise, person-respecting language may reduce blame and social distance without hiding risk or disagreement.
Observe: Selected existing stigma items, open-text explanation and lived/living-knowledge review. No single measure is treated as definitive.
P5 · Avoid false reassurance
Visitors should understand that non-use is the safest option and that naloxone, a buddy, reduced use or preparation cannot make substance use safe.
Observe: Comprehension checks for limits, emergency priority and the distinction between risk reduction and safety guarantees.
Evaluation before celebration
How TRDP should test the idea
- Freeze the version.Name the exact page, date and wording each person reviewed.
- Review safety and dignity separately.Use Canadian clinical/first-aid, pharmacist, accessibility and compensated lived/living-knowledge review.
- Test real tasks.Ask people to find emergency action, naloxone access and a suitable pathway on a phone—without coaching.
- Measure more than agreement.Record comprehension, wrong turns, accessibility barriers, intended action, optional follow-through and unintended harm.
- Publish the full lesson.Retain contrary feedback, null results and corrections. A view, share, citation or publication is not evidence of reduced stigma.
Use the free resources
Start where you are
Emergency knowledge comes first. The guides are free, require no account and do not require a personal story.
Sources and review limits
Read the foundation
- Health Canada · Substance Use Spectrum
- Health Canada · Naloxone
- Health Canada · Opioid awareness and stigma resources
- Health Canada · Substance use treatment
- Canadian take-home naloxone guidance · CMAJ
- Canadian Red Cross opioid-harm-reduction program evaluation
- Public support for harm reduction among Canadian adults
- Systematic review of substance-use stigma measures
Sources checked 12 October 2026. This note uses Canadian official guidance and peer-reviewed research. It is a bounded scan, not a systematic review. Indigenous-specific adaptation requires Indigenous leadership. Public attribution remains The Real DOPE Project.